$0.70
0.65%
NYSE, Apr 21, 07:38 pm CET
ISIN
US44916K1060
Symbol
HYPR

Hyperfine Stock price

$0.70
-0.58 45.62% 1M
-0.30 30.39% 6M
-0.18 20.90% YTD
-0.21 23.51% 1Y
-2.80 80.11% 3Y
-9.31 93.05% 5Y
-9.31 93.05% 10Y
NYSE, Closing price Thu, Apr 17 2025
+0.03 4.11%
ISIN
US44916K1060
Symbol
HYPR
Sector

Key metrics

Market capitalization $54.18m
Enterprise Value $16.78m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.30
P/S ratio (TTM) P/S ratio 4.20
P/B ratio (TTM) P/B ratio 1.04
Revenue growth (TTM) Revenue growth 16.84%
Revenue (TTM) Revenue $12.89m
EBIT (operating result TTM) EBIT $-43.22m
Free Cash Flow (TTM) Free Cash Flow $-39.15m
Cash position $37.67m
EPS (TTM) EPS $-0.56
P/E forward negative
P/S forward 3.46
EV/Sales forward 1.07
Short interest 4.01%
Show more

Is Hyperfine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Hyperfine Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Hyperfine forecast:

2x Buy
50%
2x Hold
50%

Analyst Opinions

4 Analysts have issued a Hyperfine forecast:

Buy
50%
Hold
50%

Financial data from Hyperfine

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13 13
17% 17%
100%
- Direct Costs 7 7
11% 11%
54%
5.89 5.89
24% 24%
46%
- Selling and Administrative Expenses 26 26
13% 13%
199%
- Research and Development Expense 23 23
0% 0%
175%
-42 -42
10% 10%
-328%
- Depreciation and Amortization 1.01 1.01
4% 4%
8%
EBIT (Operating Income) EBIT -43 -43
10% 10%
-335%
Net Profit -41 -41
8% 8%
-316%

In millions USD.

Don't miss a Thing! We will send you all news about Hyperfine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hyperfine Stock News

Neutral
Business Wire
6 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.
Neutral
Seeking Alpha
about one month ago
Hyperfine, Inc. (NASDAQ:HYPR ) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Brandon Carney - B. Riley Young Li - Jefferies Operator Ladies and gentlemen, thank you for standing by.
Neutral
GlobeNewsWire
about one month ago
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and provided a business update.
More Hyperfine News

Company Profile

Hyperfine, Inc. is a medical device development company, which is engaged in the development of, MRI solutions and non-invasive neural monitoring technology. The company was founded by Jonathan M. Rothberg on February 25, 2014 and is headquartered in Guilford, CT.

Head office United States
CEO Maria Sainz
Employees 111
Founded 2014
Website www.hyperfine.io

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today